Position paper on the safety/efficacy profile of Direct Oral Anticoagulants in patients with Chronic Kidney Disease: Consensus document of Società Italiana di Nefrologia (SIN), Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) and Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET).

J Nephrol 2020 Jul 31. Epub 2020 Jul 31.

University of Milan-Bicocca, Milano, Italy.

Direct oral anticoagulants (DOAC) are mostly prescribed to prevent cardioembolic stroke in patients with non-valvular atrial fibrillation (AF). An increasing number of guidelines recommend DOAC in AF patients with preserved renal function for the prevention of thromboembolism and an increased use of DOAC in daily practice is recorded also in elderly patients. Aging is associated with a reduction of glomerular filtration rate and impaired renal function, regardless of the cause, increases the risk of bleeding. Multiple medication use (polypharmacy) for treating superimposed co-morbidities is common in both elderly and chronic kidney disease (CKD) patients and drug-drug interaction may cause accumulation of DOAC, thereby increasing the risk of bleeding. There is uncertainty on the safety profile of DOAC in patients with CKD, particularly in those with severely impaired renal function or end stage renal disease, due to the heterogeneity of studies and the relative paucity of data. This document reports the position of three Italian scientific societies engaged in the management of patients with atrial fibrillation who are treated with DOAC and present with CKD.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40620-020-00768-3DOI Listing
July 2020

Publication Analysis

Top Keywords

renal function
12
chronic kidney
8
direct oral
8
risk bleeding
8
kidney disease
8
atrial fibrillation
8
società italiana
8
impaired renal
8
doac patients
8
della trombosi
8
oral anticoagulants
8
patients
7
doac
6
co-morbidities common
4
rate impaired
4
filtration rate
4
common elderly
4
glomerular filtration
4
function increases
4
increases risk
4

References

(Supplied by CrossRef)

RCP Makam et al.
PLoS ONE 2018

SR Vazquez et al.
Hematology 2018

GR Shroff et al.
Am J Kidney Dis 2018

KE Chan et al.
J Am Coll Cardiol 2016

E Grandone et al.
Semin Thromb Hemost 2019

AA Angheloiu et al.
Int J Cardiol 2019

A Koertge et al.
Blood Purif 2018

KCW Leung et al.
J Nephrol 2019

N Bansal et al.
Circulation 2013

X Yao et al.
J Am Coll Cardiol 2017

K Dahal et al.
Chest 2016

Similar Publications